• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与多种原发性恶性肿瘤相关的遗传改变。

Genetic alterations associated with multiple primary malignancies.

机构信息

Department of Surgery, Skaraborg Hospital, Lidköping, Sweden.

Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

出版信息

Cancer Med. 2021 Jul;10(13):4465-4477. doi: 10.1002/cam4.3975. Epub 2021 May 31.

DOI:10.1002/cam4.3975
PMID:34057285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8267160/
Abstract

Breast cancer (BC) patients are frequently at risk of developing other malignancies following treatment. Although studies have been conducted to elucidate the etiology of multiple primary malignancies (MPM) after a BC diagnosis, few studies have investigated other previously diagnosed primary malignancies (OPPM) before BC. Here, genome-wide profiling was used to identify potential driver DNA copy number alterations and somatic mutations that promote the development of MPMs. To compare the genomic profiles for two primary tumors (BC and OPPM) from the same patient, tumor pairs from 26 young women (≤50 years) diagnosed with one or more primary malignancies before breast cancer were analyzed. Malignant melanoma was the most frequent OPPM, followed by gynecologic- and hematologic malignancies. However, significantly more genetic alterations were detected in BC compared to the OPPM. BC also showed more genetic similarity as a group than the tumor pairs. Clonality testing showed that genetic alterations on chromosomes 1, 3, 16, and 19 were concordant in both tumors in 13 patients. TP53 mutations were also found to be prevalent in BC, MM, and HM. Although all samples were classified as genetically unstable, chromothripsis-like patterns were primarily observed in BC. Taken together, few recurrent genetic alterations were identified in both tumor pairs that can explain the development of MPMs in the same patient. However, larger studies are warranted to further investigate key driver mutations associated with MPMs.

摘要

乳腺癌(BC)患者在治疗后常常有发生其他恶性肿瘤的风险。虽然已经有研究致力于阐明 BC 诊断后发生多种原发性恶性肿瘤(MPM)的病因,但很少有研究调查 BC 之前发生的其他已诊断原发性恶性肿瘤(OPPM)。在这里,我们使用全基因组分析来鉴定潜在的驱动 DNA 拷贝数改变和体细胞突变,以促进 MPM 的发生。为了比较同一患者的两个原发性肿瘤(BC 和 OPPM)的基因组谱,对 26 名≤50 岁的患有一种或多种原发性恶性肿瘤的年轻女性(年轻 BC 患者)的肿瘤对进行了分析。恶性黑色素瘤是最常见的 OPPM,其次是妇科和血液系统恶性肿瘤。然而,与 OPPM 相比,BC 中检测到的遗传改变明显更多。BC 作为一个群体也比肿瘤对显示出更多的遗传相似性。克隆性检测显示,在 13 名患者的两个肿瘤中,染色体 1、3、16 和 19 上的遗传改变是一致的。还发现 TP53 突变在 BC、MM 和 HM 中普遍存在。尽管所有样本均被归类为遗传不稳定,但在 BC 中主要观察到染色体重排样模式。总之,在两个肿瘤对中发现的可解释同一患者 MPM 发生的反复发生的遗传改变很少。然而,需要更大的研究来进一步调查与 MPM 相关的关键驱动突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/57cac68b2c37/CAM4-10-4465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/fc502b8b73ba/CAM4-10-4465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/9199c99dc8a6/CAM4-10-4465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/29fe86a2f337/CAM4-10-4465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/57cac68b2c37/CAM4-10-4465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/fc502b8b73ba/CAM4-10-4465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/9199c99dc8a6/CAM4-10-4465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/29fe86a2f337/CAM4-10-4465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/8267160/57cac68b2c37/CAM4-10-4465-g001.jpg

相似文献

1
Genetic alterations associated with multiple primary malignancies.与多种原发性恶性肿瘤相关的遗传改变。
Cancer Med. 2021 Jul;10(13):4465-4477. doi: 10.1002/cam4.3975. Epub 2021 May 31.
2
Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.南非患者原发性乳腺癌的拷贝数改变模式及其对功能细胞通路的影响。
Int J Oncol. 2018 Dec;53(6):2745-2757. doi: 10.3892/ijo.2018.4589. Epub 2018 Oct 10.
3
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.多个原发性黑色素瘤患者的种系和体细胞突变:下一代测序研究。
BMC Cancer. 2019 Aug 5;19(1):772. doi: 10.1186/s12885-019-5984-7.
4
Recurrent TP53 missense mutation in cancer patients of Arab descent.阿拉伯裔癌症患者中TP53基因复发性错义突变
Fam Cancer. 2017 Apr;16(2):295-301. doi: 10.1007/s10689-016-9951-z.
5
Mutation analysis and mRNA expression of trail-receptors in human breast cancer.人乳腺癌中TRAIL受体的突变分析及mRNA表达
Int J Cancer. 2002 Nov 10;102(2):117-28. doi: 10.1002/ijc.10694.
6
Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.通过候选基因分析检测原发性眼眶黑色素瘤中的 SF3B1、EIF1AX 和 GNAQ 突变。
BMC Cancer. 2018 Dec 17;18(1):1262. doi: 10.1186/s12885-018-5190-z.
7
Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.基于基因突变分析、拷贝数改变和 DNA 甲基化分析的中枢神经系统黑色素细胞肿瘤的综合基因组分类。
Clin Cancer Res. 2018 Sep 15;24(18):4494-4504. doi: 10.1158/1078-0432.CCR-18-0763. Epub 2018 Jun 11.
8
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.乳腺癌脑转移的突变谱分析:脑转移灶与原发性乳腺癌靶向测序的配对分析。
Oncotarget. 2015 Dec 22;6(41):43731-42. doi: 10.18632/oncotarget.6192.
9
Uncovering the genomic heterogeneity of multifocal breast cancer.揭示多灶性乳腺癌的基因组异质性。
J Pathol. 2015 Aug;236(4):457-66. doi: 10.1002/path.4540. Epub 2015 May 7.
10
Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.墨西哥早发性乳腺癌患者中 TP53 基因种系突变的流行率。
BMC Cancer. 2019 Feb 1;19(1):118. doi: 10.1186/s12885-019-5312-2.

引用本文的文献

1
Two case reports of breast cancer combined with synchronous primary intrahepatic cholangiocarcinoma/mixed liver cancer.两例乳腺癌合并同步原发性肝内胆管癌/混合性肝癌病例报告。
Medicine (Baltimore). 2024 Nov 29;103(48):e40653. doi: 10.1097/MD.0000000000040653.
2
Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities.原发性肺癌与血液系统恶性肿瘤共存的新趋势:临床病理特征和基因异常的综合分析
Cancer Cell Int. 2024 Feb 24;24(1):84. doi: 10.1186/s12935-024-03264-x.
3
Clinical and genetic characteristics in lymphoma patients with a second solid malignancy.

本文引用的文献

1
Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018.2007年至2018年间瑞典西部乳腺癌患者先前诊断出的多种原发性恶性肿瘤。
Breast Cancer Res Treat. 2020 Nov;184(1):221-228. doi: 10.1007/s10549-020-05822-z. Epub 2020 Aug 1.
2
The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.病理学在评估癌症体细胞分子改变中的主导作用:欧洲病理学学会立场文件。
Virchows Arch. 2020 Apr;476(4):491-497. doi: 10.1007/s00428-020-02757-0. Epub 2020 Mar 2.
3
Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.
患有第二种实体恶性肿瘤的淋巴瘤患者的临床和遗传特征。
Front Oncol. 2023 Jul 21;13:1152290. doi: 10.3389/fonc.2023.1152290. eCollection 2023.
4
Factors Predicting the Final Diagnosis in Image-Guided Percutaneous Needle Biopsy for Suspected Spinal Tumors.影像引导下经皮穿刺针吸活检疑似脊柱肿瘤最终诊断的预测因素
J Clin Med. 2023 Jun 26;12(13):4292. doi: 10.3390/jcm12134292.
5
Multiple primary malignancies in 788 Chinese patients with diffuse large B-cell lymphoma.788 例弥漫性大 B 细胞淋巴瘤患者的多原发恶性肿瘤。
Cancer Med. 2023 Jul;12(13):14112-14119. doi: 10.1002/cam4.6070. Epub 2023 May 21.
6
Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report.膀胱、前列腺和肺中携带TP53和MEK1突变并伴有严重心血管疾病的同步三原发性恶性肿瘤:一例报告。
Open Med (Wars). 2022 Dec 14;17(1):2046-2051. doi: 10.1515/med-2022-0616. eCollection 2022.
7
A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience.沙特多原发实体恶性肿瘤患者类型和生存模式的描述性研究:30 年的三级保健中心经验。
Curr Oncol. 2022 Jul 13;29(7):4941-4955. doi: 10.3390/curroncol29070393.
乳腺癌与多原发恶性肿瘤:病例报告及文献复习。
In Vivo. 2019 Jul-Aug;33(4):1313-1324. doi: 10.21873/invivo.11605.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Clonal relatedness in tumour pairs of breast cancer patients.乳腺癌患者肿瘤对的克隆相关性。
Breast Cancer Res. 2018 Aug 9;20(1):96. doi: 10.1186/s13058-018-1022-y.
6
Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors.基于二代测序检测一名患有四个异时性原发性肿瘤患者的胚系和体细胞改变。
Gynecol Oncol Rep. 2018 Apr 18;24:94-98. doi: 10.1016/j.gore.2018.04.004. eCollection 2018 May.
7
Somatic mutations in early onset luminal breast cancer.早发性管腔型乳腺癌中的体细胞突变
Oncotarget. 2018 Apr 27;9(32):22460-22479. doi: 10.18632/oncotarget.25123.
8
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis.1997年至2013年间一名女性患者5种原发性恶性肿瘤的异时性和同时性发生:一项伴有胚系和体细胞基因分析的病例报告
Case Rep Oncol. 2017 Nov 16;10(3):1006-1012. doi: 10.1159/000484403. eCollection 2017 Sep-Dec.
9
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.鉴定多种癌症类型中的驱动拷贝数改变,并将其应用于药物重定位。
Mol Oncol. 2017 Oct;11(10):1459-1474. doi: 10.1002/1878-0261.12112. Epub 2017 Aug 3.
10
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.对10万个人类癌症基因组的分析揭示了肿瘤突变负荷的全貌。
Genome Med. 2017 Apr 19;9(1):34. doi: 10.1186/s13073-017-0424-2.